AMPH CIK: 1297184

Amphastar Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.32
FY22:
0.38
FY23:
0.49
FY24:
0.53
FY25:
0.64
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.35
FY22:
0.36
FY23:
1.02
FY24:
1.04
FY25:
0.99
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.67
FY22:
0.74
FY23:
1.51
FY24:
1.58
FY25:
1.63

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
0.09
FY23:
0.23
FY24:
0.17
FY25:
0.16
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.12
FY22:
0.12
FY23:
0.65
FY24:
0.67
FY25:
0.68
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.45
FY22:
0.53
FY23:
0.64
FY24:
0.73
FY25:
0.79
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.67
FY22:
0.74
FY23:
1.51
FY24:
1.58
FY25:
1.63

All amounts in billions USD Data source:SEC EDGAR